Detalhe da pesquisa
1.
Real-World Treatment Patterns in Patients With HER2-Amplified Metastatic Colorectal Cancer: A Clinical-Genomic Database Study.
J Natl Compr Canc Netw
; 21(8): 805-812.e1, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549907
2.
Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.
Cancer
; 126(14): 3219-3228, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32365229
3.
Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test.
Cancer
; 123(22): 4363-4371, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28787086
4.
ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.
Front Oncol
; 14: 1339302, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38406801
5.
Pan-Tumor Analytical Validation and Osimertinib Clinical Validation in EGFR Mutant Non-Small-Cell Lung Cancer, Supporting the First Next-Generation Sequencing Liquid Biopsy in Vitro Diagnostic.
J Mol Diagn
; 26(1): 73-84, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37981090
6.
Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages.
Diagnostics (Basel)
; 14(9)2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38732326
7.
Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs.
J Cancer Educ
; 27(3): 467-77, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22610836
8.
Novel Genomic Differences in Cell-Free Circulating DNA Profiles of Young- Versus Older-Onset Colorectal Cancer.
J Adolesc Young Adult Oncol
; 10(3): 336-341, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32915106
9.
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34095713
10.
Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis.
Clin Lung Cancer
; 21(6): 545-552.e1, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32665165
11.
Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent.
Cancer Genet
; 224-225: 12-20, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29778231
12.
Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
J Clin Oncol
; 35(22): 2568-2575, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28514183
13.
Spectrum of mismatch repair gene mutations and clinical presentation of Hispanic individuals with Lynch syndrome.
Cancer Genet
; 212-213: 1-7, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28449805
14.
Unexpected CDH1 Mutations Identified on Multigene Panels Pose Clinical Management Challenges.
JCO Precis Oncol
; 1: 1-12, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172483
15.
Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.
Mol Diagn Ther
; 17(1): 31-47, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23355100
16.
Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results.
J Clin Oncol
; 30(10): 1058-63, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22355048